Modeling the kidney with human pluripotent cells: Applications for toxicology and organ repair

IF 6.1 Q1 TOXICOLOGY
SooWan Lee , Evan M. McCabe , Theodore P. Rasmussen
{"title":"Modeling the kidney with human pluripotent cells: Applications for toxicology and organ repair","authors":"SooWan Lee ,&nbsp;Evan M. McCabe ,&nbsp;Theodore P. Rasmussen","doi":"10.1016/j.cotox.2022.100345","DOIUrl":null,"url":null,"abstract":"<div><p><span>Acute kidney damage<span> and dysfunction is a significant medical problem that is brought about by disease or by drug-induced toxicity. Though this problem has long been recognized, our understanding of human kidney damage has relied heavily upon the use of animal models<span> and the study of human kidneys after damage has already occurred. Recent advances in the field of stem cell research now make it possible to investigate the dynamic mechanisms of damage that occur in the kidneyin human renal cells derived from human pluripotent stem cells (hPSCs). In this review, we briefly summarize normal human kidney development<span> and describe how this knowledge has been used to inform strategies for the directed differentiation of hPSCs to renal cell types and kidney organoids. We also review recent translational advances in the use of such platforms to investigate molecular and cellular mechanisms of nephrotoxicity and elucidation of modes of action of drug-induced kidney toxicity as mediated by specific drugs of concern. Finally, we discuss the prospects for the use of cell-based therapeutics to reverse extant kidney damage </span></span></span></span><em>in vivo</em><span>, and eventually, the goal of restoration of renal function with stem-cell-derived organs.</span></p></div>","PeriodicalId":37736,"journal":{"name":"Current Opinion in Toxicology","volume":"31 ","pages":"Article 100345"},"PeriodicalIF":6.1000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468202022000225","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Acute kidney damage and dysfunction is a significant medical problem that is brought about by disease or by drug-induced toxicity. Though this problem has long been recognized, our understanding of human kidney damage has relied heavily upon the use of animal models and the study of human kidneys after damage has already occurred. Recent advances in the field of stem cell research now make it possible to investigate the dynamic mechanisms of damage that occur in the kidneyin human renal cells derived from human pluripotent stem cells (hPSCs). In this review, we briefly summarize normal human kidney development and describe how this knowledge has been used to inform strategies for the directed differentiation of hPSCs to renal cell types and kidney organoids. We also review recent translational advances in the use of such platforms to investigate molecular and cellular mechanisms of nephrotoxicity and elucidation of modes of action of drug-induced kidney toxicity as mediated by specific drugs of concern. Finally, we discuss the prospects for the use of cell-based therapeutics to reverse extant kidney damage in vivo, and eventually, the goal of restoration of renal function with stem-cell-derived organs.

用人类多能细胞模拟肾脏:毒理学和器官修复的应用
急性肾损害和功能障碍是由疾病或药物毒性引起的重要医学问题。虽然这个问题早已被认识到,但我们对人类肾脏损伤的理解在很大程度上依赖于动物模型的使用,以及对已经发生损伤的人类肾脏的研究。干细胞研究领域的最新进展使研究由人多能干细胞(hPSCs)衍生的人肾细胞发生肾脏损伤的动力学机制成为可能。在这篇综述中,我们简要地总结了正常人类肾脏的发育,并描述了如何利用这些知识来指导将造血干细胞定向分化为肾细胞类型和肾类器官的策略。我们还回顾了利用这些平台研究肾毒性的分子和细胞机制以及阐明特定药物介导的药物诱导肾毒性的作用模式的最新翻译进展。最后,我们讨论了使用基于细胞的治疗方法在体内逆转现存肾脏损伤的前景,并最终实现了用干细胞来源的器官恢复肾功能的目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Opinion in Toxicology
Current Opinion in Toxicology Pharmacology, Toxicology and Pharmaceutics-Toxicology
CiteScore
10.40
自引率
0.00%
发文量
43
期刊介绍: The aims and scope of Current Opinion in Toxicology is to systematically provide the reader with timely and provocative views and opinions of the highest qualified and recognized experts on current advances in selected topics within the field of toxicology. The goal is that Current Opinion in Toxicology will be an invaluable source of information and perspective for researchers, teachers, managers and administrators, policy makers and students. Division of the subject into sections: For this purpose, the scope of Toxicology is divided into six selected high impact themed sections, each of which is reviewed once a year: Mechanistic Toxicology, Metabolic Toxicology, Risk assessment in Toxicology, Genomic Toxicology, Systems Toxicology, Translational Toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信